Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians

Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study

Efficacy of Methylene blue mediated Photodynamic therapy for primary localized cutaneous amyloidosis treatment in Asians, pilot study.

Inclusion Criteria:

• Patients, aged > 18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathological findings.

Exclusion Criteria:

• Those with systemic disease associated cutaneous amyloidosis
• Pregnancy or lactating woman
• Those who are allergic to urea, olive oil
• Those who are photosensitive to ultraviolet radiation
• Those who had been previously treated with any of which -medications, radiation, laser within 3 months and 1 month for topical therapy